EMVision Medical Devices Ltd
ASX:EMV.AX
2.14 (AUD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 6.973 | 4.36 | 1.699 | 1.551 | 1.414 | 0.493 |
| Cost of Revenue
| 0.411 | 0.342 | 0.243 | 0.114 | 0 | 0 | 0 |
| Gross Profit
| -0.411 | 6.631 | 4.117 | 1.585 | 1.551 | 1.414 | 0.493 |
| Gross Profit Ratio
| 0 | 0.951 | 0.944 | 0.933 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 4.697 | 2.012 | 2.325 | 2.708 | 2.935 | 1.96 | 0.956 |
| General & Administrative Expenses
| 0 | 1.527 | 1.288 | 0.957 | 0.728 | 2.124 | 0.198 |
| Selling & Marketing Expenses
| 0 | 7.047 | 6.611 | 6.406 | 1.45 | 0.132 | 0.183 |
| SG&A
| 8.369 | 8.574 | 7.898 | 7.363 | 2.178 | 2.124 | 0.381 |
| Other Expenses
| 0 | 6.973 | 4.36 | 1.749 | 1.601 | 0.289 | 0 |
| Operating Expenses
| 13.066 | 10.586 | 10.224 | 10.071 | 5.114 | 4.373 | 1.337 |
| Operating Income
| -13.477 | -10.928 | -10.467 | -10.185 | -5.114 | -2.959 | -1.337 |
| Operating Income Ratio
| 0 | -1.567 | -2.401 | -5.995 | -3.296 | -2.092 | -2.714 |
| Total Other Income Expenses Net
| 4.598 | 4.556 | 2.368 | 0.505 | 0.98 | -0.001 | 0.492 |
| Income Before Tax
| -8.878 | -6.372 | -8.1 | -9.679 | -4.133 | -2.959 | -0.845 |
| Income Before Tax Ratio
| 0 | -0.914 | -1.858 | -5.697 | -2.664 | -2.092 | -1.715 |
| Income Tax Expense
| -6.149 | -2.501 | -1.99 | -1.281 | -0.658 | -0.279 | -0 |
| Net Income
| -2.73 | -3.871 | -6.109 | -8.399 | -3.476 | -2.959 | -0.845 |
| Net Income Ratio
| 0 | -0.555 | -1.401 | -4.944 | -2.24 | -2.092 | -1.715 |
| EPS
| -0.034 | -0.05 | -0.081 | -0.12 | -0.057 | -0.063 | -0.015 |
| EPS Diluted
| -0.034 | -0.05 | -0.081 | -0.12 | -0.057 | -0.063 | -0.015 |
| EBITDA
| -13.066 | -10.586 | -10.224 | -10.071 | -5.114 | -2.959 | -1.337 |
| EBITDA Ratio
| 0 | -1.518 | -2.345 | -5.928 | -3.296 | -2.092 | -2.714 |